Allworth Financial’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$112 Hold
104
– – ﹤0.01% 5132
2026
Q2
$112 Sell
104
-13
-11% -$38 ﹤0.01% 5017
2026
Q1
$439 Buy
117
+28
+31% +$110 ﹤0.01% 4757
2025
Q4
$315 Buy
89
+84
+1,680% +$341 ﹤0.01% 4629
2025
Q3
$20 Buy
+5
New +$16 ﹤0.01% 4827

Other funds holding ADCT

Allworth Financial's ADCT Position: Q3 2026 in Review

Allworth Financial held its ADC Therapeutics (ADCT) position steady in Q3 2026 at 104 shares worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #5132.

Allworth Financial first reported a position in ADCT in Q3 2025 and has held it in 5 quarters since. The position peaked at $439 in Q1 2026. 75 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.

  • Allworth Financial held 104 shares of ADC Therapeutics worth $112 as of Q3 2026.
  • Allworth Financial left its ADC Therapeutics share count unchanged in Q3 2026.
  • ADC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5132 holding.
  • Allworth Financial first reported a position in ADC Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Allworth Financial's ADC Therapeutics position peaked at $439 in Q1 2026.
  • 75 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.